Unexplained weight loss (UWL), a decrease in body weight without an identifiable cause, often presents a diagnostic challenge for clinicians. This phenomenon, which is often associated with underlying serious disease, necessitates a comprehensive approach for evaluation.
The first step in evaluating UWL should be a thorough history and physical examination. Clinicians should inquire about changes in appetite, dietary habits, and physical activity. It is also important to consider medications, psychosocial factors, and systemic symptoms such as fever, pain, or fatigue. Physical examination should focus on signs of malnutrition, malignancy, and endocrine or metabolic disorders.
Initial laboratory testing should include a complete blood count, metabolic panel, liver function tests, thyroid function tests, and urinalysis. Depending on the clinical suspicion, additional tests such as tumor markers, autoimmune panels, or imaging studies may be warranted.
In elderly patients, UWL may be the only sign of a serious underlying condition such as malignancy or depression. In such cases, a multidisciplinary approach involving geriatricians, psychiatrists, and dietitians may be beneficial. In patients with HIV or tuberculosis, UWL may indicate disease progression or suboptimal treatment response.
If initial evaluation does not reveal a cause, clinicians should monitor the patient's weight and symptoms. If weight loss continues or new symptoms develop, referral to a specialist may be necessary. Early referral can facilitate timely diagnosis and treatment, potentially improving patient outcomes.
UWL is a complex clinical presentation that warrants a comprehensive, stepwise approach. By combining a meticulous history and physical examination with targeted laboratory investigations, clinicians can effectively narrow down potential causes. In cases where the etiology remains elusive, ongoing monitoring and specialist referral can ensure optimal patient care.
1.
For MDS-Related Anemia, Telomerase Inhibitor Approved.
2.
Efficacy and safety of intravenous chemotherapy in children with intraocular retinoblastoma
3.
Admissions, medical schools, costs, and eligibility requirements information for FNB Onco-Anesthesia.
4.
Treating Depression: Crucial for Recovery From Fibromyalgia
5.
In postmenopausal women with hormone receptor-positive tumors, obesity increases the risk of breast cancer recurrence.
1.
Empowering Oncology with Data: Cloud Security, Real-World Evidence, and Clinical Insights
2.
Immune Regulation of Blood Cell Development
3.
Exploring the Effects of Radiation Therapy on Cystitis: A Journey to Better Health
4.
Transformative Frameworks in Oncology for Better Care
5.
Liposomal Doxorubicin and Mitomycin in Modern Cancer Treatment
1.
International Conference on Oncology, Cancer Prevention and Public Health
2.
International Conference on Cancer Nursing and Rehabilitation Strategies
3.
International Conference on Best Practices in Oncology, Cardiology and Critical Care
4.
International Conference on Innovations in Critical Care for Oncology and Cardiology
5.
International Symposium on Oncology, Cardiology and Critical Care Innovations
1.
Targeting Oncologic Drivers: A New Approach to Lung Cancer Treatment
2.
Newer Immunotherapies for Myeloma- A Comprehensive Overview
3.
Understanding the causes of anemia in adults beyond nutritional deficiencies
4.
Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part III
5.
Guideline Recommendations of Lorlatinib as First-Line Treatment for ALK+ NSCLC
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation